YOLFTbeta
Biovica International AB (publ)

Biovica International AB (publ)

BIOVIC-B · ST · Healthcare / Biotechnology

0.304SEK-0.00 (-1.30%)

Price History

Full chart

Market Stats

Previous Close0.308
Open0.308
Day Range0.302 – 0.309
52-Week Range0.27 – 0.63
Volume102.14K
Market Cap89.62M
P/E (TTM)0.00
Forward P/E15.06
EPS-0.19
Dividend Yield0.00%
Beta1.15
50-Day Avg0.4223
200-Day Avg0.3862

About

Biovica International AB (publ), a biotech company, develops and commercializes blood-based biomarker assays for oncologists monitor cancer progression in the European Union, the United States, and Asia. The company engages in the development of DiviTum TKa, a monitoring tool for patients with early or metastatic breast cancer undergoing treatment with CDK4/6 inhibitors. It serves cancer institutes and pharmaceutical companies. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Theis Kipling
  • Employees24
  • HeadquartersDag Hammarskjölds väg 54B, Uppsala, Sweden, 752 37, Sweden
  • Websitehttps://www.biovica.com

Leadership

  • Mr. Theis KiplingChief Executive Officer · b. 1982
  • Mr. Anders MorenCFO & Secretary · b. 1965
  • Ms. Hanna RitzénSenior VP of Global Marketing & Business Development · b. 1979
  • Mr. Henrik Winther D.V.M., Ph.D.Head & Senior VP of Pharma Services · b. 1966
  • Mr. Hector TamburiniHead of US Laboratory Operations, Regulatory & Quality · b. 1962

Financials

Income Statement

Currency: SEK2014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue4.05M459.00K2.43M632.00K2.72M3.00M1.67M2.08M2.04M3.38M7.29M8.62M13.38M
Growth (%)--88.65%+429.85%-74.01%+330.85%+10.36%-44.39%+24.30%-1.54%+65.48%+115.43%+18.23%+55.24%
Cost of Revenue441.54K-3.67M-4.37M-4.46M-5.58M-5.63M-6.82M-3.19M-2.62M-1.23M413.00K535.00K83.43M
Gross Profit3.60M4.13M6.80M5.09M8.30M8.64M8.49M5.27M4.67M4.62M6.88M8.08M-70.05M
Gross Margin89.08%898.69%279.69%805.70%304.92%287.42%507.84%253.73%228.17%136.44%94.33%93.79%-523.52%
Operating Expense8.19M10.62M11.40M19.93M26.26M30.36M38.30M45.45M64.77M115.07M133.72M93.92M0
Operating Income-4.58M-6.50M-4.60M-14.84M-17.96M-21.72M-29.82M-40.18M-60.10M-110.46M-126.84M-85.84M-70.05M
Operating Margin-113.31%-1415.69%-189.10%-2347.94%-659.42%-722.73%-1784.32%-1934.57%-2938.92%-3264.10%-1739.99%-995.93%-523.52%
EBITDA-4.00M-5.18M-4.17M-13.02M-15.22M-18.50M-25.65M-36.56M-53.47M-105.96M-119.51M-76.22M-61.75M
EBITDA Margin-98.86%-1128.32%-171.42%-2060.60%-558.87%-615.77%-1534.77%-1760.42%-2614.87%-3131.24%-1639.31%-884.36%-461.52%
Net Income-5.37M-7.04M-5.03M-14.86M-18.06M-21.56M-30.32M-39.48M-60.00M-110.49M-124.82M-87.62M-69.86M
Net Income Margin-132.80%-1534.42%-206.87%-2350.79%-663.39%-717.34%-1814.36%-1900.96%-2934.13%-3265.13%-1712.25%-1016.64%-522.12%
R&D---1.30M1.30M1.45M2.62M7.58M13.00M5.35M5.09M--
R&D as % of Total Revenue---205.54%47.70%48.32%156.73%364.95%635.79%158.10%69.79%--
Interest Expense788.24K545.00K182.00K9.00K54.00K35.00K443.00K60.00K78.00K281.00K289.00K917.00K396.00K
Interest Expense % of Total Revenue19.49%118.74%7.48%1.42%1.98%1.16%26.51%2.89%3.81%8.30%3.96%10.64%2.96%

Balance Sheet

Currency: SEK2014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets14.39M17.76M28.73M97.18M80.77M60.86M90.26M192.65M151.63M172.29M131.41M64.95M107.75M
Total Liabilities4.02M9.44M3.25M5.64M7.06M8.76M12.04M9.99M27.54M33.65M34.77M21.74M21.42M
Total Equity10.36M8.32M25.48M91.55M73.71M52.10M78.22M182.66M124.09M138.63M96.64M43.21M86.33M
Cash454.12K1.05M867.00K65.41M42.13M16.83M40.78M145.35M77.41M114.33M79.41M24.41M70.41M
Total Debt1.52M82.00K388--3.57M3.45M2.42M13.25M10.45M7.83M4.65M4.30M
Net Debt1.06M-965.00K-866.61K-65.41M-42.13M-16.83M-37.32M-142.93M-64.17M-103.87M-71.58M-19.76M-66.11M

Cash Flow

Currency: SEK2014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow-922.00K-9.38M-11.09M-14.88M-17.97M-24.78M-34.41M-52.13M-94.64M-114.58M-85.37M-62.81M
Investing Cash Flow--3.89M-12.91M-5.92M-8.46M-7.33M-7.04M-3.56M-3.40M-2.78M-585.00K-287.00K-474.00K
Financing Cash Flow-3.56M22.11M81.55M55.74M55.74M55.74M142.66M-136.00K122.01M79.50M30.93M109.36M
Capital Expenditure03.89M4.94M5.83M8.59M7.33M7.04M3.56M3.40M2.78M146.00K287.00K474.00K
Free Cash Flow--2.97M-14.33M-16.93M-23.47M-25.30M-31.82M-37.97M-55.52M-97.42M-114.72M-85.65M-63.28M
FCF to OCF--322.02%152.68%152.61%157.69%140.79%128.39%110.35%106.52%102.94%100.13%100.34%100.75%

Earnings

Report DateAug 31, 2017Jan 3, 2018Mar 21, 2018Jun 15, 2018Aug 30, 2018Dec 6, 2018Mar 21, 2019Jun 14, 2019Aug 29, 2019Dec 5, 2019Mar 12, 2020Jun 5, 2020Aug 27, 2020Dec 3, 2020Mar 18, 2021Jun 17, 2021Aug 30, 2021Dec 1, 2021Mar 15, 2022Jun 16, 2022Aug 31, 2022Dec 15, 2022Mar 16, 2023Jun 21, 2023Sep 6, 2023Nov 28, 2023Mar 14, 2024Jun 18, 2024Sep 12, 2024Nov 29, 2024Mar 13, 2025Jun 18, 2025Sep 11, 2025Dec 18, 2025Mar 18, 2026Jun 17, 2026Sep 10, 2026
EPS Estimate---0.27-0.31--0.26-0.28-0.26---------0.14-0.20-0.31-0.40---0.60-0.45-0.30-0.30-0.58-0.40-0.22-0.24-0.28-0.31-0.11-0.09-0.08--
EPS Actual-0.20-0.23-0.35-0.24-0.23-0.32-0.34-0.49-0.33-0.25-0.32-0.45-0.35-0.29-0.38-0.42-0.43-0.51-0.50-0.67-0.73-0.81-0.64-0.81-0.70-0.56-0.44-0.47-0.27-0.23-0.23-0.21-0.18-0.06-0.06-0.07-0.07
Surprise---29.63%22.58%--23.08%-21.43%-88.46%---------207.14%-155.00%-61.29%-67.50%---6.67%-80.00%-133.33%-86.67%24.14%-17.50%-22.73%4.17%17.86%32.26%-63.64%33.33%25.00%--
TimingPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap89.62M
Enterprise Value44.64M
Trailing P/E0.00
Forward P/E15.06
Price / Sales6.00
Price / Book1.35
EPS-0.19
Book Value0.228
Revenue (TTM)14.93M
Gross Profit (TTM)14.47M
EBITDA-70.92M
Profit Margin0.00%
Operating Margin-505.71%
Return on Equity-156.59%
Return on Assets-60.88%
Shares Outstanding277.49M
Shares Float166.60M
Beta1.15
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%